Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0029463 (
osteosarcoma
)
16,637
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
EYA2
is the developmental transcription factor and phosphatase, playing an important role in numerous species in regulating cell death and differentiation. Recent studies showed that
EYA2
is dysregulated and involved in the progression of various cancers. However, the expression and role of
EYA2
in
osteosarcoma
remains unclear. Here, we found that
EYA2
expression was evidently upregulated
osteosarcoma
(OS) tissue and cell lines. Next, we predicted
EYA2
-targeting miRNAs, which was further evaluated using a dual luciferase reporter assay. We found that miR-219a-5p significantly repressed
EYA2
expression via binding to the 3'-UTR of
EYA2
. Furthermore, overexpressed miR-219a-5p significantly repressed OS cell invasion and migration, which was reversed by overexpressed
EYA2
. While silenced miR-219a-5p induced OS cell invasion and migration, which was reversed by silenced
EYA2
. In conclusion, our study revealed that miR-219a-5p function as tumour suppressor regulates OS cell invasiveness by repressing
EYA2
expression.
...
PMID:miR-219a-5p represses migration and invasion of osteosarcoma cells via targeting EYA2. 3044 83